Concepedia

Rivka Levy

RL

51

Publications

4.5K

Citations

34

H-Index

1982

Active since

Affiliations

Weizmann Institute of Science(Current)

Tel Aviv University

Hebrew University of Jerusalem

National Institutes of Health

Kaplan Medical Center

Rivka Levy is an author at Weizmann Institute of Science specializing in medicine, pharmacology, and neuroscience.

ORCID

Top concepts

Publications per year

1982–2024

51

Publications

51

Biophysical constraints of optogenetic inhibition at presynaptic terminals

Mathias Mahn, Matthias Prigge, Shiri Ron et al. · Nature Neuroscience · 2016 · 372 citations · Full text

, , +9

High-efficiency optogenetic silencing with soma-targeted anion-conducting channelrhodopsins

Mathias Mahn, Lihi Gibor, Pritish Patil et al. · Nature Communications · 2018 · 323 citations · Full text

Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase

Zvi Vogel, Jacob Barg, Rivka Levy et al. · Journal of Neurochemistry · 1993 · 298 citations

Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells

Ewa Kozela, Maciej Pietr, Ana Juknat et al. · Journal of Biological Chemistry · 2009 · 277 citations · Full text

The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling

Michael Bayewitch, Tomer Avidor‐Reiss, Rivka Levy et al. · FEBS Letters · 1995 · 212 citations · Full text

Rows per page

1–5 of 51